Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学PET/CT Radiomics, Theranostics

Uwe Haberkorn

MD

🏢Heidelberg University Hospital🌐Germany

Professor of Nuclear Medicine

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Uwe Haberkorn at Heidelberg University Hospital is a pioneer in PET imaging and theranostics, with major contributions to PSMA and FAPI PET tracers alongside PET-based radiomic biomarker development in oncology. His work bridges tracer pharmacokinetics, tumor biology, and quantitative PET image analysis. He has developed novel radioligands that have translated to clinical use in prostate cancer and solid tumor theranostics. His research includes PET radiomics for treatment response prediction and patient selection for radioligand therapies.

Share:

🧪Research Fields 研究领域

PET radiomics
PET/CT imaging biomarkers
FDG-PET cancer response
theranostics cancer
PET-guided radiation

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Uwe Haberkorn 的研究动态

Follow Uwe Haberkorn's research updates

留下邮箱,当我们发布与 Uwe Haberkorn(Heidelberg University Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment